E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs

NCT06443385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7872

Last updated 2026-02-11

No results posted yet for this study

Summary

This study will test e-mails to encourage engagement with the Minnesota prescription monitoring program (PMP/PDMP) and will evaluate the effect of these e-mails on PMP/PDMP use and controlled substance prescribing.

Conditions

  • Opioid Prescribing
  • Prescription Drug Misuse

Interventions

BEHAVIORAL

PDMP Legal Mandate E-mail

E-mails highlighting the state's legal requirements to use the PDMP. There will be one initial email and one follow-up email one month later.

BEHAVIORAL

PDMP Clinical Benefit E-mail

E-mails highlighting the clinical benefits of having access to the PDMP and checking the PDMP before prescribing opioids. There will be one initial email and one follow-up email one month later.

Sponsors & Collaborators

  • University of Southern California

    collaborator OTHER
  • Bowdoin College

    collaborator OTHER
  • Abdul Latif Jameel Poverty Action Lab

    collaborator OTHER
  • Minnesota Management and Budget

    collaborator UNKNOWN
  • Minnesota Board of Pharmacy

    collaborator OTHER
  • Columbia University

    lead OTHER

Principal Investigators

  • Adam Sacarny, PhD · Columbia University

  • Mireille Jacobson, PhD · University of Southern California

  • Tatyana Avilova, PhD · Bowdoin College

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-17
Primary Completion
2024-09-14
Completion
2025-09-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06443385 on ClinicalTrials.gov